IDiyas

For the Inventor, By the Inventor

Richland, MI, United States of America

Paul D May

USPTO Granted Patents = 18

Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 134(Granted Patents)


Location History:

  • Bristol, WI (US) (1992)
  • Richland, MI (US) (1994 - 2005)
  • Kalamazoo, MI (US) (2006)

Company Filing History:

goldMedal8 out of 523 
 
Pharmacia & Upjohn Company
 patents
silverMedal4 out of 4,177 
 
Abbott Laboratories Corporation
 patents
bronzeMedal2 out of 4,455 
 
Pfizer Corporation
 patents
4. 1 out of 200 
 
Pharmacia Corporation
 patents
5. 3 out of 832,680 
Other
 patents

Years Active: 1992-2006

Loading Chart...
18 patents (USPTO):
1. 7119209 - Process for preparing indolinone derivatives (2006-10-10),
2. 7105547 - Antimicrobial 1-aryl dihydropyridone compounds (2006-09-12),
3. 6861438 - Antiviral agents (2005-03-01),
4. 6852731 - Antiviral compounds (2005-02-08),
5. 6410585 - Inhibitors of protein tyrosine phosphatase (2002-06-25),
6. 6353023 - Inhibitors of protein tyrosine phosphatase (2002-03-05),
7. 6329545 - Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus (2001-12-11),
8. 6274580 - Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus (2001-08-14),
9. 6184216 - Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus (2001-02-06),
10. 6177453 - Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus (2001-01-23),
11. 6166080 - Aminoquanidine carboxylates for the treatment of obesity (2000-12-26),
12. 5994577 - Aminoguanidine carboxylates for the treatment of non-insulin-dependent (1999-11-30),
13. 5955617 - Aminoguanidine carboxylate lactams for the treatment of (1999-09-21),
14. 5866589 - Alkyl substituted piperadinyl and piperazinyl anti-AIDS compounds (1999-02-02),
15. 5382670 - Platelet activating factor antagonists (1995-01-17),

Title: The Innovative Contributions of Paul D. May

Introduction

Paul D. May is a notable inventor based in Richland, Michigan, who has made significant contributions to the field of pharmaceuticals. With a total of 18 patents to his name, he has developed innovative processes and compounds that have the potential to impact medical treatments.

Latest Patents

Among his latest patents is a process for preparing indolinone derivatives, which refers to a method for synthesizing these compounds as defined in the specification. Additionally, he has developed antimicrobial 1-aryl dihydropyridone compounds, which serve as antibacterial agents, including pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Paul D. May has worked with prominent companies such as Pharmacia & Upjohn Company and Abbott Laboratories Corporation. His work in these organizations has allowed him to advance his research and contribute to the development of new pharmaceutical products.

Collaborations

Paul has collaborated with several professionals in his field, including Scott D. Larsen and Valerie Ann Vaillancourt. These collaborations have enriched his work and fostered innovation in the pharmaceutical industry.

Conclusion

In summary, Paul D. May's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…